Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Driving and drug regulation.

A J Isaacs1

  • 1Medicines Division, DHSS, London, England.

International Clinical Psychopharmacology
|May 1, 1988
PubMed
Summary

Regulatory bodies evaluate new medicines for quality, safety, and efficacy. Drug applications require statements on driving and machinery operation effects, supported by scientific data and appearing on labels and data sheets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-procedural time spent in atrial fibrillation using intermittent ECG monitoring is associated with arrhythmia recurrence after ablation: the ISOLATION cohort study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only.

Health technology assessment (Winchester, England)·2007
Same author

UK women doctors' use of hormone replacement therapy: 10-year follow up.

Climacteric : the journal of the International Menopause Society·2005
Same author

The Newcastle exercise project. Organisational aspects may influence adherence rates.

BMJ (Clinical research ed.)·2000
Same author

Commercial partnerships in chronic disease management: proceeding with caution.

BMJ (Clinical research ed.)·2000
Same author

Primary aldosteronism in general practice.

Lancet (London, England)·1999

Area of Science:

  • Pharmacovigilance and Drug Regulation
  • Medicinal Chemistry and Pharmacology

Background:

  • The UK Licensing Authority is responsible for evaluating new medicines.
  • European Community (EC) regulations mandate product characteristic summaries for drug applications.

Purpose of the Study:

  • To outline the regulatory requirements for assessing new medicines.
  • To detail the information required regarding a drug's effect on driving and machinery operation.

Main Methods:

  • Review of statutory duties and regulatory guidelines.
  • Analysis of requirements for product characteristic summaries and data sheets.

Main Results:

  • Medicines are evaluated for quality, safety, and efficacy.
  • Drug applications must include statements on effects on driving and machinery operation.
  • Claims and warnings must be scientifically substantiated and appear on labels and data sheets.

Conclusions:

  • Regulatory frameworks ensure drug safety and inform public use.
  • Standardized warnings, like those for antihistamines, are implemented.
  • Further methods for public warnings, such as package inserts, are under consideration.

Related Experiment Videos